Imsight is an innovative company using artificial intelligence to aid diagnosis. Based on artificial intelligence deep learning and computer medical image analysis technology, the company has developed a series of fast and accurate intelligent medical imaging products, mainly involves pathology, radiology, radiotherapy and other areas. Our series perform in-depth analysis on big data of medical images, act as a fast and accurate auxiliary tool and thereby improving the accuracy and efficiency of clinical diagnosis and treatment.
Imsight has branches in Shenzhen, Hong Kong, Chengdu and Guiyang. Its markets are widely distributed across China. Till June 2018, our company has successively completed Series A funding with hundreds of millions RMB from China Merchants Innovation Investment Management Co., Ltd, Shenzhen Capital Group Co., Ltd and Lenovo Capital. At present, Imsight has established a long-term and stable research collaborations with hospitals, both domestic and abroad. At the same time, Imsight also has in-depth cooperation with many medical device manufacturers and digital platforms.